Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (4): 108-114.doi: 10.6040/j.issn.1673-3770.0.2023.214

• Original Article • Previous Articles    

Rosai-Dorfman disease of the bilateral neck and nasopharynx: a case report and review of related cases

LI Yaru, XU Zhenju, WANG Xiaojun, FU Tao, YUAN Yue, WU Ce   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, Affiliated Hospital of Qingdao University, Qingdao 266000, Shandong, China
  • Published:2024-07-09

Abstract: Objective In order to explore the etiology, clinical manifestations, diagnostic basis, and treatment experience of Rosai-Dorfman disease(RDD). Methods The clinical data of a patient with RDD were retrospectively analyzed, and the hospitalization data of patients diagnosed with RDD in our hospital in the last 10 years were summarized. Results By searching the case system of our hospital, three patients with non-RDD pathological results were excluded, and six patients with RDD pathological results were screened out, plus seven patients in this case. The male-to-female ratio was 4:3, and the patients were aged 16-65 years. There were two cases(2/7)involving the skin, one case(1/7)involving the brain, one case(1/7)involving the trachea, two cases(2/7)involving the cervical lymph nodes, and one case(1/7)involving the nasal sinus, parotid gland, orbit, armpit, and cervical lymph nodes. Conclusion Classical RDD often manifests as bilateral cervical lymph node enlargement, which may be accompanied by fever, night sweats, fatigue, and weight loss. Extranodal RDD and mixed RDD are rare in clinical practice. However, as they affect the function of important organs, cause serious consequences, and have a difficult diagnosis, they need to be differentiated from other diseases. At present, there is no unified standard treatment for RDD. For patients with clinical symptoms, surgical treatment can quickly relieve clinical symptoms. Although RDD is a benign lesion, extranodal RDD may have serious consequences because of its location; therefore, it should be paid attention to in the clinic.

Key words: Rosai-Dorfman disease, Sinus histiocytosis with massive lymphadenopathy, Immunohistochemistry, Diagnose, Therapy

CLC Number: 

  • R766.3
[1] Destombes P. Adenitis with lipid excess, in children or young adults, seen in the Antilles and in Mali.(4 cases)[J]. Bull Soc Pathol Exot Filiales, 1965, 58(6): 1169-1175
[2] Rosai J, Dorfman RF. Sinus Histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity[J]. Arch Pathol, 1969, 87(1): 63-70
[3] Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages[J]. Blood, 2016, 127(22): 2672-2681. doi:10.1182/blood-2016-01-690636
[4] Abla O, Jacobsen E, Picarsic J, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease[J]. Blood, 2018, 131(26): 2877-2890. doi:10.1182/blood-2018-03-839753
[5] 张亚男, 潘国庆, 李睿, 等. 结外Rosai-Dorfman病的相关临床病理特征及文献复习[J]. 分子诊断与治疗杂志, 2022, 14(6): 1068-1071. doi: 10.3969/j.issn.1674-6929.2022.06.042 ZHANG Yanan, PAN Guoqing, LI Rui, et al. The clinicopathological characteristics and literature review of extranodal rosai-dorfman disease[J]. Journal of Molecular Diagnosis and Therapy, 2022, 14(6): 1068-1071. doi: 10.3969/j.issn.1674-6929.2022.06.042
[6] Rajyalakshmi R, Akhtar M, Swathi Y, et al. Cytological diagnosis of rosai-dorfman disease: a study of twelve cases with emphasis on diagnostic challenges[J]. J Cytol, 2020, 37(1): 46-52. doi:10.4103/JOC.JOC_4_19
[7] Tummidi S, Singh HK, Reddy PA, et al. ROSE in rosai-dorfman-destombes(RDD)disease: a cytological diagnosis[J]. Eur J Med Res, 2021, 26(1): 34. doi:10.1186/s40001-021-00505-x
[8] Cohen Aubart F, Haroche J, Emile JF, et al. Rosai-Dorfman disease: diagnosis and therapeutic challenges[J]. Rev Med Interne, 2018, 39(8): 635-640. doi:10.1016/j.revmed.2018.02.011
[9] Dalia S, Sagatys E, Sokol L, et al. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment[J]. Cancer Control, 2014, 21(4): 322-327. doi:10.1177/107327481402100408
[10] 刘旭, 胡余昌, 唐立华. Rosai-Dorfman病研究进展[J]. 中华病理学杂志, 2017, 46(6): 443-446. doi:10.3760/cma.j.issn.0529-5807.2017.06.023
[11] Goyal G, Young JR, Koster MJ, et al. The mayo clinic Histiocytosis working group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: erdheim-Chester disease, Langerhans cell Histiocytosis, and rosai-dorfman disease[J]. Mayo Clin Proc, 2019, 94(10): 2054-2071. doi:10.1016/j.mayocp.2019.02.023
[12] 杨冉冉, 鞠侯雨, 任国欣, 等. 36例口腔颌面-头颈部朗格汉斯细胞组织细胞增多症临床及预后分析[J]. 中国口腔颌面外科杂志, 2021, 19(1): 52-58. doi:10.19438/j.cjoms.2021.01.011 YANG Ranran, JU Houyu, REN Guoxin, et al. Clinical and prognostic analysis of Langerhans cell Histiocytosis in oral maxillofacial head and neck: report of 36 consecutive cases[J]. China Journal of Oral and Maxillofacial Surgery, 2021, 19(1): 52-58. doi:10.19438/j.cjoms.2021.01.011
[13] 马晓松, 汪步海, 梁一晨, 等. B细胞非霍奇金淋巴瘤靶向药物治疗研究进展[J]. 现代肿瘤医学, 2022, 30(12):2272-2275. doi: 10.3969/j.issn.1672-4992.2022.12.034 MA Xiaosong, WANG Buhai, LIANG Yichen, et al. Advances in targeted drug therapy for B-cell non-Hodgkin's lymphoma[J]. Journal of Modern Oncology, 2022, 30(12)2272-2275. doi: 10.3969/j.issn.1672-4992.2022.12.034
[14] Abraham ZS, Francis Z, Ngaiza AI, et al. Histocytopathological diagnosis of Rosai-Dorfman disease: case report[J]. Clin Case Rep, 2022, 10(2): e05412. doi:10.1002/ccr3.5412
[15] Al-Khateeb TH. Cutaneous rosai-dorfman disease of the face: a comprehensive literature review and case report[J]. J Oral Maxillofac Surg, 2016, 74(3): 528-540. doi:10.1016/j.joms.2015.09.017
[16] Ahmed A, Crowson N, Magro CM. A comprehensive assessment of cutaneous Rosai-Dorfman disease[J]. Ann Diagn Pathol, 2019, 40: 166-173. doi:10.1016/j.anndiagpath.2019.02.004
[17] Varrassi M, Corridore A, Tommasino E, et al. MR imaging of cerebral involvement of Rosai-Dorfman disease: a single-centre experience with review of the literature[J]. Radiol Med, 2021, 126(1): 89-98. doi:10.1007/s11547-020-01226-7
[18] Zhang XS, Yin W, Guo YW, et al. Rosai-Dorfman disease of the central nervous system: a clinical, radiological, and prognostic study of 12 cases[J]. Front Oncol, 2022, 12: 1013419. doi:10.3389/fonc.2022.101341
[19] Al-Maghrabi H, Elmahrouk A, Feteih M, et al. Rosai-Dorfman disease with pulmonary involvement mimicking bronchogenic carcinoma[J]. J Cardiothorac Surg, 2020, 15(1): 37. doi:10.1186/s13019-020-1085-6
[20] 崔哲卿, 濮田, 刘蕾, 等. 累及腮腺、双侧鼻腔及颈部淋巴结rosai-dorfman病一例 [J]. 中国临床案例成果数据库, 2022, 4(1): 873. doi:10.3760/cma.j.cmcr.2022.e00873 CUI Zheqing, PU Tian, LIU Lei, et al. A case of rosai-dorfman disease involving parotid gland, bilateral nasal cavity and cervical lymph nodes [J]. China clinical case database. 2022, 4(1): 873. doi:10.3760/cma.j.cmcr.2022.e00873
[21] 李秋慧, 朱芳, 刘涛, 等. 放射治疗皮肤rosai-dorfman疾病的病例报告[J]. 中国临床案例成果数据库, 2022, 4(1): 6889. doi: 10.3760/cma.j.cmcr.2022.e06889 LI Qiuhui, ZHU Fang, LIU Tamia, et al. Case report of skin rosai-dorfman disease treated by radiotherapy [J]. China clinical case achievement database, 2022, 4(1): 6889. doi: 10.3760/cma.j.cmcr.2022.e06889
[22] Wan M, Ding AJ, Liu H, et al. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: a case report[J]. Photodiagnosis Photodyn Ther, 2020, 31: 101879. doi:10.1016/j.pdpdt.2020.101879
[23] Li M, Shi L, Luo M, et al. Successful treatment of Rosai-Dorfman disease using in situ photoimmunotherapy[J]. Indian J Dermatol Venereol Leprol, 2017, 83(3): 332-336. doi:10.4103/ijdvl.IJDVL_356_16
[1] WANG Jingsong, YU Can, ZHANG Xi, DENG Qicheng, XIE Zhuoliang, ZHAO Rui, WEN Bei, LIU Hai. Expression and clinical significance of KRT4 in laryngeal carcinoma and adjacent normal mucosal tissues [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 12-17.
[2] YANG Kaiyan, TANG Fengzhu, QIN Qicai, LI Xuxiang, FENG Dayi, NONG Fengjing, YANG Qiuyun. Expression of abnormal spindle-like microcephaly associated protein in nasopharyngeal carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 18-25.
[3] LI Yang, LIU Dong, CAO Wenjie. Meta-analysis of the effect of red-light therapy on spherical equivalent, axial length, and choroidal thickness in myopic children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 74-81.
[4] DING Longqing, LIU Yiming, CHENG Zhuo, SUN Ran, LIANG Hui. Observation on the therapeutic effect of oropharyngeal exercise on adult obstructive sleep apnea hypopnea syndrome [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(6): 153-158.
[5] ZHOU Yijing, ZOU Jianyin, YI Hongliang, WU Hongmin. Expression of TGFBI in head and neck squamous cell carcinoma and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 85-95.
[6] TU Qiaoling, LI Yufeng, PENG Jun. Advances in anti-PD-L1/PD-1 therapy and non-coding RNA regulation in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 135-141.
[7] ZHANG Miao, YANG Yingchao, FU Zhihui, SU Kaiming. Research progress in the relationship between autonomic nervous system dysfunction and nasal diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 142-148.
[8] HUANG Yanli, LI Junzheng. The mechanism of copper-induced tumor cell death and its research progress in cancer therapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(5): 198-205.
[9] LUO Yiwen, XIAO Yongtao, GAO Minqian, YANG Jiayi, YANG Haidi. Progress in acoustic therapy for chronic subjective tinnitus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 13-23.
[10] DONG Hongsong, WANG Chunli, YU Yanping, CHEN Tao, NIE Guohui. A randomized controlled clinical trial of sound therapy combined with medication in the treatment of chronic subjective tinnitus [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 30-37.
[11] XU Haiyan, CAO Wei, FAN Dachuan. Efficacy of compound sound therapy for patients with tinnitus and sudden deafness [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(4): 38-45.
[12] HAN Feiyan, WANG Ying. Clinical analysis of 13 cases of neurilemmomas in the nasal cavity and paranasal sinuses [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 21-25.
[13] REN Wei, LI Jia, ZHANG Xiong, ZHANG Shengjie. Electroacupuncture combined with manual moxibustion in the treatment of Meige syndrome: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 63-66.
[14] AI Ziqin, LI Junzheng. Advances in immune vaccines for head and neck squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(2): 143-150.
[15] HUANG Hengfeng, MA Kunpeng, YANG Di, ZHANG Lijun, ZHANG Shenglin. Expression and clinical significance of miR-181b-5P and EPB41L3 protein in laryngeal squamous cell carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2023, 37(1): 41-46.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!